SRx Health Solutions Cancels 18.8 Million Shares

An update from SRx Health Solutions ( (SRXH) ) is now available.

On August 14, 2025, SRx Health Solutions, Inc. announced the cancellation of approximately 18.8 million shares of its capital stock. This action was part of a Settlement Agreement with certain founders and former officers of its Canadian subsidiary, SRx Canada, and their affiliates. The forfeited shares represented about 60% of the total issued and outstanding shares prior to the agreement. The company plans to pursue legal remedies against former officers not included in the settlement to recover lost value for its stockholders.

The most recent analyst rating on (SRXH) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on SRx Health Solutions stock, see the SRXH Stock Forecast page.

Spark’s Take on SRXH Stock

According to Spark, TipRanks’ AI Analyst, SRXH is a Neutral.

SRXH faces significant financial challenges, with declining revenues and negative cash flows being major concerns. Technical indicators also suggest bearish momentum. However, the recent earnings call provided some optimism with improved profitability measures and strategic growth plans. Valuation metrics are weak, showing financial distress. Overall, while there are positive signs from recent strategic moves, substantial risks remain.

To see Spark’s full report on SRXH stock, click here.

More about SRx Health Solutions

SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The company has a network spanning all ten Canadian provinces, offering comprehensive, integrated, and customized specialty healthcare services aimed at improving the wellness of Canadians.

Average Trading Volume: 732,628

Technical Sentiment Signal: Strong Sell

Current Market Cap: $11.02M

See more data about SRXH stock on TipRanks’ Stock Analysis page.